Company Analysis

Cabaletta Bio, Inc. (CABA)

Nasdaq: CABA · Biological Products, (No Diagnostic Substances) · Philadelphia, PA · filing with the SEC since 2018
Grade5.6
◀ Past 5.9● Present 5.5▶ Future 5.6
6 est.

Who runs Cabaletta Bio, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Nichtberger Steven
President & CEO. First filing Oct 2019, latest Mar 2, 2026, 3 filings in all.
Officers reporting now
7
of 12 people with a filing in the last fifteen months
Directors reporting now
5
14 people on the record since 2019
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Nichtberger StevenPresident & CEOOct 2019Mar 2, 2026none
Binder GwendolynPresident, Science & Tech.Oct 2019Mar 2, 2026none
Marda AnupChief Financial OfficerOct 2019Mar 2, 2026none
Chang David J.Chief Medical OfficerOct 2019Mar 2, 2026none
Das ArunChief Business OfficerJan 2022Mar 2, 2026none
Gerard MichaelGeneral CounselSep 2021Mar 2, 2026none
Gavel SteveChief Commercial OfficerOct 2025Jan 21, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bollard CatherinedirectorOct 2019Jun 10, 2026none
Brun Scott C.directorJun 2021Jun 10, 2026none
Henriques Richard C JrdirectorOct 2019Jun 10, 2026none
Simon MarkdirectorOct 2019Jun 10, 2026none
Tomasello ShawndirectorJul 2023Jun 10, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CABA · research, not advice